To identify circulating proteins influencing Coronavirus Disease 2019 (COVID-19) susceptibility
and severity, we undertook a two-sample Mendelian randomization (MR) study, rapidly …

Metabolic processes can influence disease risk and provide therapeutic targets. By conducting
genome-wide association studies of 1,091 blood metabolites and 309 metabolite ratios, …

Schizophrenia is a severe psychiatric disorder that profoundly affects cognitive, behavioral
and emotional processes. The wide spectrum of symptoms and clinical variability in …

Rupture of an intracranial aneurysm leads to subarachnoid hemorrhage, a severe type of
stroke. To discover new risk loci and the genetic architecture of intracranial aneurysms, we …

Background Increased vitamin D levels, as reflected by 25-hydroxy vitamin D (25OHD)
measurements, have been proposed to protect against COVID-19 based on in vitro, observational…

The substantial investments in human genetics and genomics made over the past three
decades were anticipated to result in many innovative therapies. Here we investigate the extent …

Type I interferons (IFN-I) play a critical role in human antiviral immunity, as demonstrated by
the exceptionally rare deleterious variants of IFNAR1 or IFNAR2. We investigated five …

A recent report found that rare predicted loss-of-function (pLOF) variants across 13 candidate
genes in TLR3- and IRF7-dependent type I IFN pathways explain up to 3.5% of severe …

We report here the description of a nonconsanguineous family with 2 affected individuals
with a recessively inherited juvenile motor neuron disease. Exome sequencing of these 2 …

Despite advances in COVID-19 management, identifying patients evolving toward death
remains challenging. To identify early predictors of mortality within 60 days of symptom onset (…